Table 1. Sample characteristics.
| Patient | Age | Gender | Hepatitis | Serum AFP level(ng/mL) | Metastasis | Glisson capsule invasion | Tumor size (mm) | Multiple liver nodules |
|---|---|---|---|---|---|---|---|---|
| P10 | 59 | M | HBV | 670.10 | No | – | 35 | - |
| P14 | 50 | M | HBV | 12483 | No | + | 50 | - |
| P17 | 37 | M | HBV | 4.47 | No | + | 41 | - |
| P21 | 62 | M | HBV | 266.5 | No | + | 32 | - |
| P24 | 76 | M | HCV | 5.84 | No | + | 70 | - |
| P26 | 59 | M | HBV | 3.73 | No | – | 6 | - |
| P29 | 69 | M | HBV | 6.90 | No | + | 160 | synchronous |
| P36 | 61 | M | NBNC | 1.11 | No | + | 80 | - |
| P40 | 19 | F | NBNC | 2.85 | No | – | 29 | - |
| L24 | 63 | M | HBV | 2975 | No | + | 70 | synchronous |
| L26 | 47 | M | HBV | 5375 | Yes | + | 130 | - |
| L44 | 72 | M | HBV | 303.8 | No | + | 40 | synchronous |
| L134 | 66 | M | HBV | 60500 | No | + | 50 | - |
| H19 | 59 | M | NBNC | 54.84 | No | + | 26 | - |
| L6 | 48 | M | NBNC | 55.1 | Yes | + | 180 | - |
| L21 | 41 | M | HBV | 4.70 | Yes | + | 50 | - |
| L25 | 72 | M | HBV | 1110 | No | + | 80 | - |
| L30 | 50 | M | HBV | 260.9 | No | – | 25 | - |
| L36 | 64 | M | HBV | 244.6 | Yes | + | 65 | synchronous |
| L39 | 67 | M | HBV | 321.1 | No | + | 55 | synchronous |
| L45 | 71 | M | HBV | 4606 | Yes | + | 12 | - |
| L46 | 18 | F | HBV | 37979 | No | + | 70 | - |
| L49 | 45 | M | HBV | 6528 | No | + | 60 | synchronous |
| L52 | 50 | M | HBV | 3.03 | Yes | + | 55 | synchronous |
| L53 | 61 | M | HBV | 1.90 | No | + | 30 | - |
| L54 | 52 | M | HBV | 26.53 | No | + | 20 | - |
| L55 | 55 | M | HBV | 1.82 | No | + | 34 | - |
| L57 | 58 | F | HBV | 2.55 | Yes | + | 55 | synchronous |
| L61 | 42 | M | HBV | 3.38 | No | + | 20 | synchronous |
| L64 | 64 | M | HBV | 774.2 | No | + | 10 | - |
| L68 | 54 | F | NBNC | 23784 | No | + | 22 | - |
| L72 | 40 | M | HBV | 1816 | No | + | 30 | - |
| L73 | 74 | M | NBNC | 5.90 | No | + | 30 | - |
| L85 | 76 | M | NBNC | 2.10 | No | + | 34 | - |
| L154 | 47 | M | HBV | 62.47 | Yes | + | 105 | - |
| L195 | 67 | M | NBNC | 3.01 | Yes | + | 80 | - |
| H1 | 37 | M | HBV | 1810 | No | – | 55 | - |
| H2 | 67 | M | HBV | 3103 | No | + | 40 | - |
| H3 | 48 | M | HBV | 2.07 | No | – | 35 | - |
| H4 | 68 | M | HBV | 15.87 | No | + | 35 | - |
| H5 | 71 | M | HBV | 11.65 | No | + | 35 | - |
| H6 | 56 | M | HBV | 33571 | No | + | 57 | - |
| H7 | 52 | M | HBV | 2100 | Yes | – | 35 | - |
| H8 | 52 | M | NBNC | 5.30 | No | + | 65 | - |
| H9 | 37 | M | HBV | >60500 | Yes | – | 95 | - |
| H11 | 46 | M | HBV | 4.64 | No | – | 45 | - |
| H13 | 52 | F | NBNC | 2.45 | No | + | 22 | - |
| H16 | 75 | M | NBNC | 4.14 | Yes | + | 87 | synchronous |
| H22 | 47 | M | HBV | 5.78 | No | + | 40 | - |
| H25 | 60 | M | HBV | 61.54 | No | – | 25 | - |
| H27 | 65 | M | HBV | 5.34 | No | + | 70 | - |
| H28 | 63 | M | HBV | 3396 | No | + | 40 | - |
| H29 | 52 | M | HBV | 66.50 | No | + | 22 | - |
| H30 | 58 | M | HBV | 6.52 | Yes | + | 58 | synchronous |
| H31 | 42 | M | HBV | 3.31 | No | + | 30 | - |
| H32 | 62 | M | HBV | 570 | No | + | 28 | - |
| H33 | 46 | M | HBV | 3780 | No | + | 21 | synchronous |
| H34 | 64 | M | HBV | 36541 | Yes | + | 140 | - |
| H35 | 47 | F | HCV | 250.5 | No | – | 22 | - |
| H36 | 39 | M | HBV | 8.10 | Yes | + | 22 | synchronous |
| H37 | 63 | M | HBV | 208 | No | + | 40 | - |
| H38 | 48 | M | NBNC | 3.07 | No | + | 33 | - |
| H39 | 66 | M | HBV | 82.81 | No | + | 34 | - |
Note: The nine samples used for sequencing are shown in bold. The six samples with validated fusion CRYL1-IFT88 are shown in italic.